Express Press Release Distribution

Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel

EPR Archived News

Archived News 2012
~ April
~ March
~ February
~ January

Archived News 2011
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2010
Archived News 2009
Archived News 2008
Archived News 2007
Archived News 2006
Archived News 2005
Archived News 2004

 

Global Health Progress Stresses Importance of Product Development Partnerships

 

 

Released on: August 20, 2010, 5:10 am
Author: Global Health Progress
Industry: Healthcare

Helen Coster’s recent commentary in her new Forbes blog Good Work addresses the issue of how product development partnerships (PDPs) can develop and improve treatments for neglected diseases like malaria, leishmaniasis, and Chagas disease.

Coster notes, “These diseases affect the world’s poorest people, and they often get ignored by pharmaceutical companies for a simple economic reason: there is no way that considerable investment in research will be recouped in drug sales.”

Coster’s entry highlights the work of some of the best-known PDPs, such as the Drugs for Neglected Disease Initiative, Global Alliance for Vaccines and Immunization, the International AIDS Vaccine Initiative and the Global Fund to Fight AIDS, Tuberculosis & Malaria. Coster also highlighted the significant funding of PDPs by The Bill and Melinda Gates Foundation.

In closing, Coster invites her readers to discuss the PDP approach to eradicating neglected diseases and what role, if any, the pharmaceutical industry, philanthropists and other global organizations should play in the fight.

Global Health Progress also believes that public-private product development partnerships are invaluable in expanding the capacity of research and development (R&D) on innovative drugs and vaccines for neglected diseases. These partnerships help by harnessing the technical expertise and resources of the private sector with the approach of universities, research institutes and other public organizations.

For example, research-based biopharmaceutical companies routinely partner with numerous organizations and dedicate hundreds of millions of dollars and their expertise to researching neglected diseases and to developing the next generation of medicines and vaccines. These collaborations are critical in creating practical and innovative solutions in fighting diseases of the developing world, and part of GHP’s mission is to highlight the successes of these partnerships.

About Global Health Progress:
Global Health Progress provides a platform for companies, governments, public health leaders, universities, foundations, and other stakeholders to share experiences and best practices and to forge new partnerships. Global Health Progress also supports efforts to raise awareness and mobilize resources to address health challenges in the developing world by bringing local leaders together with international health experts, policymakers, donor governments, and the private sector.

On the Web:
www.globalhealthprogress.org
Twitter: twitter.com/globalhealth
Facebook: facebook.com/group.php?gid=35156473766
Linked-in: linkedin.com/groups?home=&gid=2972068

Contact Details: Mark Grayson
(202) 835-3460
MGrayson@phrma.org

 

WORD PDF PRINT

Back to previous page
Home page
Submit your press release